FOXP3+ T cells in uterine sarcomas are associated with favorable prognosis, low extracellular matrix expression and reduced YAP activation
Abstract Uterine sarcomas are rare but deadly malignancies without effective treatment. Immunotherapy is a promising new approach to treat these tumors but has shown heterogeneous effects in sarcoma patients. With the goal of identifying key factors for improved patient treatment, we characterized t...
Guardado en:
Autores principales: | Okan Gultekin, Jordi Gonzalez-Molina, Elin Hardell, Lidia Moyano-Galceran, Nicholas Mitsios, Jan Mulder, Georgia Kokaraki, Anders Isaksson, Dhifaf Sarhan, Kaisa Lehti, Joseph W. Carlson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eda4826495d543a98d261183c1886ac9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Radiomics and Artificial Intelligence in Uterine Sarcomas: A Systematic Review
por: Gloria Ravegnini, et al.
Publicado: (2021) -
Neoadjuvant chemotherapy for Ewing’s sarcoma family tumors of the uterine cervix: A case report
por: Masahiko Mori, et al.
Publicado: (2021) -
Uterine Preservation Treatments in Sarcomas: Oncological Problems and Reproductive Results: A Systematic Review
por: Giulia Dondi, et al.
Publicado: (2021) -
Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance
por: Elina A. Pietilä, et al.
Publicado: (2021) -
Differentiation of uterine low-grade endometrial stromal sarcoma from rare leiomyoma variants by magnetic resonance imaging
por: Yuki Himoto, et al.
Publicado: (2021)